Home > Boards > US Listed > Medical - Drugs > AcelRx Pharmaceuticals, Inc. (ACRX)

Q1 earnings coming 5/8. The update on

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Bobwins Member Profile
Member Level 
Followed By 530
Posts 17,269
Boards Moderated 42
Alias Born 10/21/03
160x600 placeholder
Dr. TJ Gan to Present at the 2019 Annual Meeting of the American Society of Anesthesiologists PR Newswire (US) - 10/16/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2019 4:06:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2019 4:52:50 PM
AcelRx Pharmaceuticals Selected to Present at the 2019 Military Health System Research Symposium PR Newswire (US) - 8/15/2019 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 6:04:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2019 4:11:11 PM
AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results PR Newswire (US) - 8/5/2019 4:05:00 PM
AcelRx to announce second quarter 2019 results and provide an update on the company's business on Monday, August 5th, 2019 PR Newswire (US) - 8/2/2019 10:12:00 AM
AcelRx added to the Russell 2000® and 3000® indexes PR Newswire (US) - 7/1/2019 2:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:06:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:05:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:03:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:03:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:01:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 6:59:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 4:50:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 6:06:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 7:11:14 AM
AcelRx announces the closing of a $25 million senior secured debt facility PR Newswire (US) - 6/3/2019 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/14/2019 6:11:56 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 5/14/2019 6:11:08 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/9/2019 8:56:02 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 8:53:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 4:06:39 PM
AcelRx Pharmaceuticals Reports First Quarter 2019 Financial Results PR Newswire (US) - 5/8/2019 4:01:00 PM
Bobwins Member Level  Thursday, 04/25/19 05:26:32 PM
Re: lakingsphan0427 post# 1128
Post # of 1179 
Q1 earnings coming 5/8. The update on progress there will be crucial to near term stock performance. The formulary wins have been significant, with most major health insurance plans including Dsuvia but hospitals will be where the actual units will be ordered and used. Not sure how long it takes for hospitals to start ordering and using the drug. Looking forward to update at the Q1 earnings conference call.

Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.

If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist